DB12055
DB12055 (MK-0767 analog) is a covalent SARS-CoV-2 3CL protease inhibitor. DB12055 has the potential for the study of dyslipidemia and diabetes mellitus.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 934017-32-0
- Formule: C20H17F3N2O5
- Masse moléculaire:422.35
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Chemical Information
-
CAS No. 934017-32-0
-
Masse moléculaire 422.35
-
Formule C20H17F3N2O5
-
SMILES
O=C(NCC1=CC=C(C(F)(F)F)C=C1)C2=CC(CC(OC(N3)=O)C3=O)=CC=C2OC
-
Synonyms
MK-0767 analog
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Ronda K Rippley, et al. Human pharmacokinetics and interconversion of enantiomers of MK-0767, a dual PPARalpha/gamma agonist. J Clin Pharmacol. 2007 Mar;47(3):323-33. [Content Brief]
[2]. Ying Wang, et al. Multidimensional virtual screening approaches combined with drug repurposing to identify potential covalent inhibitors of SARS-CoV-2 3CL protease. J Biomol Struct Dyn. 2023;41(24):15262-15285. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)